Clinical Trials Directory

Trials / Completed

CompletedNCT01403597

Evaluation of Non-ablative and Fractional Combination Treatment for Improvement in Skin's Appearance

Clinical Evaluation of the Impact of Non-ablative and Fractional Ablative Combination Treatment: a Prospective, Open Label, Single Group With Before-after Study Design

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Syneron Medical · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

The study is designed to determine the safety, efficacy, patient comfort and patient satisfaction of the combined treatment of Refirme ST and Matrix RF both devices approved under 510k clearances. The evaluations will include skin condition, physician/subject improvement assessment, and subject comfort and satisfaction score by questionnaires.

Detailed description

The Refirme ST and the Matrix RF applicators are both FDA approved devices indicated for improvement of skin appearance. The Matrix RF applicator has FDA clearance for ablation, resurfacing of the skin, and for wrinkles treatment, whereas the Refirme-ST applicator has FDA clearance for non-invasive wrinkles treatment. The combined treatment of Refirme ST and Matrix RF is intended to improve skin appearance both by enhancement of collagen production as the result of the Refirme ST primary heating of the treated area and by causing ablation and resurfacing of the skin with the Matrix RF. In the current clinical setting, each applicator is used in a separate session although there is no contra-indication preventing the usage of these applicators in the same treatment session. A combined treatment in one session is believed to be more efficient and will be more time effective for the patient and therefore will have a commercial benefit for the manufacturer.

Conditions

Interventions

TypeNameDescription
DEVICERefirme ST Applicator and Matrix RF Applicator5 treatments with combination of devices every 4 weeks to the facial (or sub facial regions).

Timeline

Start date
2011-01-01
Primary completion
2012-06-01
Completion
2012-07-01
First posted
2011-07-27
Last updated
2014-12-02

Source: ClinicalTrials.gov record NCT01403597. Inclusion in this directory is not an endorsement.